This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
Dublin: 3 °C Saturday 14 December, 2019


# novartis - Thursday 24 October, 2019

'We knew things were coming down the line': Speculation was rife over job losses in Cork

The Novartis job losses came one day after Shannon-based Molex announced 500 job cuts.

# novartis - Wednesday 23 October, 2019

Big pharma firm Novartis to cut 320 jobs at Cork plant

One of the world’s biggest pharmaceutical firms, Novartis employs 1,600 people in Ireland.

# novartis - Sunday 16 July, 2017

'Technology is the great equaliser' - how two apps for those with impaired sight are levelling the playing field

The two apps have been developed in conjunction with National Council for the Blind of Ireland (NCBI).

# novartis - Monday 16 December, 2013

First meningitis B vaccine now available privately in Ireland

The Meningitis Research Foundation has called for the vaccine to be implemented nationally for all children.

# novartis - Friday 12 April, 2013

Gilmore hits out at 'relentless criticism from the commentariat'

In an email to party members this evening the Labour leader insists that his party has helped bring Ireland from “a state of economic chaos to stability.”

# novartis - Monday 8 April, 2013

Novartis to create 100 jobs in Dublin

A day of mixed fortunes for Ireland’s job count.

# novartis - Saturday 17 March, 2012

Calls for controversial MS treatment to be made available in Ireland

MS Ireland has led calls for the drug Gilenya to be made available here after a decision by regulators in the UK. But a European agency has been investigating the manufacturer after reports of the drug’s possible role in the death of 11 people.

# novartis - Friday 20 January, 2012

European agency investigates Novartis drug following 11 deaths

The European Medicines Agency is investigating the drug Gilenya, used to treat a severe type of multiple sclerosis, to establish if it linked to the deaths of at least 11 patients.